Healthcare Professionals
Du har precis klickat på en länk som tar dig till en annan webbplats. Om du fortsätter kommer du att lämna denna webbplats och gå till en webbplats som drivs av någon annan.
Medtronic Sverige varken granskar eller kontrollerar innehållet på den andra webbplatsen och tar inget ansvar för eventuella affärstransaktioner som du utför där. Din användning av den andra webbplatsen är föremål för användarvillkoren och sekretesspolicyn på den webbplatsen.
Det är möjligt att vissa produkter på den andra platsen inte är godkända i Sverige.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Välkommen till vår information för hälso- och sjukvårdspersonal.
Här hittar du produktinformation och annan info framtagen för dig som arbetar inom vården.
Arbetar du inom ett vårdyrke?
Healthcare Professionals
NovaShield Injectable Nasal Packing and Nasal Stent is a ready-to-use gel for FESS (functional endoscopic sinus surgery). Made from chitosan, it helps to control minimal bleeding, prevent adhesions, and provide a level of antibacterial effectiveness.*
NovaShield™ Injectable Nasal Packing and Nasal Stent is a ready-to-use gel for FESS, made from chitosan. It's pre-filled in a syringe with accordion cannula and flexible tip.
Chitosan is a polymer chemical produced from chitin, a component of the hard external shell of shellfish (e.g., crab, lobster, and shrimp). Its hemostatic properties have been extensively studied in both civilian and military clinical settings.5-12
We also offer bioresorbable MeroGel®, MeroGel Injectable, and MeroPak® products made from hyaluronic acid.
See our ENT Product Catalog for more nasal packing and FESS products, including traditional nasal packing.
*In vitro efficacy is not correlated to the clinical effectiveness.
Li L, Wang N, Jin X, et al. Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid-based hydrogels for postoperative adhesion prevention. Biomaterials. 2014; 35:3903-3917.
Aziz MA, Cabral JD, Brooks HJL, et al. In vitro biocompatibility and cellular interactions of a chitosan/dextran-based hydrogel for postsurgical adhesion prevention. J Biomed Mater Res. Part B 2014; 00B:000–000.
Kourelis K, Shikani AH. Effectiveness of chitosan-based packing in 35 patients with recalcitrant epistaxis in the context of coagulopathy. Clin Otolaryngol. 2012;37(4):309-313.
Shikani AH, Chahine KA, Alqudah MA. Endoscopically guided chitosan nasal packing for intractable epistaxis. Am J Rhinol Allergy. 2011;25(1):61-63.
Rao SB, Sharma CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res. 1997; 34:21-28.
Malette WG, Quigley H, Gaines RD, Johnson ND, Rainer G. Chitosan: a new hemostatic. Ann Thorac Surg. 1983; 36:55-58.
Chou TC, Fu E, Wu CJ, Yeh JH. Chitosan enhances platelet adhesion and aggregation. Biochem Biophys Res Commun. 2003; 302:480-483.
Dutkiewicz JK. Superabsorbent materials from shellfish waste–a review. J Biomed Mater Res. 2002; 63:373-381.
Brandenberg G, Leibrock LG, Shuman R, Malette WG, Quigley H. Chitosan: a new topical hemostatic agent for diffuse capillary bleeding in brain tissue. Neurosurgery. 1984; 15:9-13.
Hirano S, Zhang M, Nakagawa M, Miyata T. Wet spun chitosan-collagen fibers, their chemical N-modifications, and blood compatibility. Biomaterials. 2000; 21:997-1003.
Belman A, Daya M, Steve M, Worley J. From the battlefield to the street—experience of a suburban fire/EMS agency with chitosan dressing. 2006; Touch Briefings: Emergency Medicine & Critical Care Review.
Wedmore I, McManus JG, Pusateri AE, Holcomb JB. A special report on the chitosan-based hemostatic dressing: experience in current combat operations. J Trauma. 2006; 60:655-658.
Chitosan as a Biomaterial
Many new biomaterials have been developed to manage uncontrolled bleeding and reduce scarring from surgery or other trauma. Chitosan is a polysaccharide derived from the shells of crustaceans (e.g., crab, shrimp). Its hemostatic properties have been extensively studied in both civilian and military settings.1-12
*In vitro efficacy is not correlated to the clinical effectiveness.
Li L, Wang N, Jin X, et al. Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid-based hydrogels for postoperative adhesion prevention. Biomaterials. 2014; 35:3903-3917.
Aziz MA, Cabral JD, Brooks HJL, et al. In vitro biocompatibility and cellular interactions of a chitosan/dextran-based hydrogel for postsurgical adhesion prevention. J Biomed Mater Res. Part B 2014; 00B:000–000.
Kourelis K, Shikani AH. Effectiveness of chitosan-based packing in 35 patients with recalcitrant epistaxis in the context of coagulopathy. Clin Otolaryngol. 2012;37(4):309-313.
Shikani AH, Chahine KA, Alqudah MA. Endoscopically guided chitosan nasal packing for intractable epistaxis. Am J Rhinol Allergy. 2011;25(1):61-63.
Ngoc Ha T, Valentine R, Moratti S, Robinson S, Hanton L, Wormald PJ. A blinded randomized controlled trial evaluating the efficacy of chitosan gel on ostial stenosis following endoscopic sinus surgery. International Forum of Allergy and Rhinology. 2013;3(7):573-580.
Rao SB, Sharma CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res. 1997; 34:21-28.
Malette WG, Quigley H, Gaines RD, Johnson ND, Rainer G. Chitosan: a new hemostatic. Ann Thorac Surg. 1983; 36:55-58.
Chou TC, Fu E, Wu CJ, Yeh JH. Chitosan enhances platelet adhesion and aggregation. Biochem Biophys Res Commun. 2003; 302:480-483.
Dutkiewicz JK. Superabsorbent materials from shellfish waste–a review. J Biomed Mater Res. 2002; 63:373-381.
Brandenberg G, Leibrock LG, Shuman R, Malette WG, Quigley H. Chitosan: a new topical hemostatic agent for diffuse capillary bleeding in brain tissue. Neurosurgery. 1984; 15:9-13.
Hirano S, Zhang M, Nakagawa M, Miyata T. Wet spun chitosan-collagen fibers, their chemical N-modifications, and blood compatibility. Biomaterials. 2000; 21:997-1003.
Belman A, Daya M, Steve M, Worley J. From the battlefield to the street—experience of a suburban fire/EMS agency with chitosan dressing. 2006; Touch Briefings: Emergency Medicine & Critical Care Review.
Wedmore I, McManus JG, Pusateri AE, Holcomb JB. A special report on the chitosan-based hemostatic dressing: experience in current combat operations. J Trauma. 2006; 60:655-658.